Tag: hemp
-
The Curious Case of Maple Leaf Green World (MGW.C)
Long time readers will remember the weird ass name of Maple Leaf Green World (MGW.C) from several years back in the cannabis space, when a group arrived from China determined to make their riches in the North American weed fields, only to end up in a small, dank, broken down greenhouse in Nevada, under a…
-
![Stocks to Watch: Lexaria Bioscience (LEXX.Q) sees gains]()
Stocks to Watch: Lexaria Bioscience (LEXX.Q) sees gains
Special Delivery Lexaria Bioscience Corp. (LEXX.Q) is a biotechnology company developing DehydraTECH™, the Company’s proprietary drug delivery technology. In addition to enhancing the speed and efficiency of orally-delivered drugs, DehydraTECH has demonstrated effectiveness in improving delivery through human skin for the potential development of topically-administered products such as patches. Through various animal studies evaluating the quantity…
-
![To Invest or Not: Pure Extracts Technologies Corp. (PULL.C)]()
To Invest or Not: Pure Extracts Technologies Corp. (PULL.C)
In this episode, we take a look at a cannabis, hemp and psychedelics extraction company based in British Columbia that goes by the name Pure Extracts Technologies Corp. (PULL.C). The company offers various derivative cannabis products such as Pure Mushrooms, which are daily supplements aimed at boosting the immune system and overall health and wellness;…
-
Xphyto (XPHY.C) bulks up executive team as Covid-19 ravages Europe
The PCR test system demonstrated clinical accuracy in detecting SARS-CoV-2 RNA within 25 minutes, making it an ideal screening tool for international airports.
-
![Discover Wellness (WLNS.C) enters the $3.5 billion global CBD market with a lean mean business model]()
Discover Wellness (WLNS.C) enters the $3.5 billion global CBD market with a lean mean business model
“The contribution of this first 550,000 kg of high-CBD biomass from SG and the completion of the Strategic Alliance agreement is a significant first step in leveraging the combined resources under the Discover Wellness umbrella,” stated Peter Cheung, Interim CEO of WLNS,
-
That was quick! Xphyto (XPHY.C) orders 9,600 Covid-19 PCR tests – stock up 67% year-to-date
“PCR tests are used to directly detect the presence of an antigen, rather than the presence of the body’s immune response, or antibodies,” states Medical Device Network, “By detecting viral RNA, which will be present in the body before symptoms of the disease are present,” the tests give a powerful early warning system.
-
![Xphyto (XPHY.C) assembles biotech/biz dream-team to launch 25-minute Covid-19 test]()
Xphyto (XPHY.C) assembles biotech/biz dream-team to launch 25-minute Covid-19 test
The PCR test system demonstrated clinical accuracy in detecting SARS-CoV-2 RNA within 25 minutes, making it an ideal screening tool for international airports.
-
![Xphyto’s (XPHY.C) lays out its ambitious Parkinson’s/Epilepsy/Depression/Multiple Sclerosis drug formulation strategy which includes heavy investment in psychedelic medicine]()
Xphyto’s (XPHY.C) lays out its ambitious Parkinson’s/Epilepsy/Depression/Multiple Sclerosis drug formulation strategy which includes heavy investment in psychedelic medicine
Xphyto describes itself as “a bioscience accelerator” “targeting growth through commercialization of its product pipeline”.
-
![Biotech Blitz: Xphyto (XPHY.C), Theralase (TLT.V), Caladrius (CLBS.Q), Volition Rx (VNRX.NYSE), Kane Biotech (KNE.V) and Bionexus (BGLC.OTC) stand & deliver]()
Biotech Blitz: Xphyto (XPHY.C), Theralase (TLT.V), Caladrius (CLBS.Q), Volition Rx (VNRX.NYSE), Kane Biotech (KNE.V) and Bionexus (BGLC.OTC) stand & deliver
On Thursday, December 17th, 2020 the Virtual Life Sciences Investor Forum (VLSIF) presents a six biotech companies.
-
![Xphyto (XPHY.C) targets industrial manufacture of psilocybin as U.S. voters weigh in on mushrooms]()
Xphyto (XPHY.C) targets industrial manufacture of psilocybin as U.S. voters weigh in on mushrooms
Today’s federal election results could change the regulatory landscape in Oregon and Washington DC, as the residents of those states will vote to decide if psilocybin should be decriminalised.
